Wedbush Securities Inc Bio Rad Laboratories, Inc. Transaction History

Wedbush Securities Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$268.26 - $339.48 $238,483 - $301,797	-889 Reduced 51.09%	851 $232,000
Q1 2024 May 14, 2024	SELL	$304.11 - $351.99 $21,591 - $24,991	-71 Reduced 3.92%	1,740 $602,000
Q4 2023 Feb 12, 2024	SELL	$269.37 - $365.04 $9,158 - $12,411	-34 Reduced 1.84%	1,811 $585,000
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $1,050 - $1,267	-3 Reduced 0.16%	1,845 $661,000
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $2,875 - $3,891	-8 Reduced 0.43%	1,848 $701,000
Q1 2023 May 09, 2023	BUY	$418.69 - $503.0 $418 - $503	1 Added 0.05%	1,856 $889,000
Q4 2022 Jan 31, 2023	BUY	$351.71 - $456.01 $1,055 - $1,368	3 Added 0.16%	1,855 $780,000
Q3 2022 Oct 18, 2022	BUY	$412.59 - $563.26 $21,042 - $28,726	51 Added 2.83%	1,852 $772,000
Q1 2022 Apr 19, 2022	SELL	$524.57 - $735.42 $3,147 - $4,412	-6 Reduced 0.33%	1,801 $1.01 Million
Q4 2021 Jan 13, 2022	SELL	$708.84 - $794.68 $2,126 - $2,384	-3 Reduced 0.17%	1,807 $1.37 Million
Q1 2021 Apr 26, 2021	BUY	$547.01 - $662.35 $990,088 - $1.2 Million	1,810 New	1,810 $1.03 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.